Lichen Meng

Title: Lichen Meng: Innovator in Pharmaceutical Chemistry

Introduction

Lichen Meng is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on tetrahydroisoquinoline derivatives. His research focuses on the preparation methods and applications of these compounds in medicine.

Latest Patents

Lichen Meng holds a patent for a tetrahydroisoquinoline derivative, which includes a preparation method and its use in therapeutic applications. This invention is particularly relevant as it serves as an angiotensin II type 2 receptor (ATR) antagonist. The patent outlines a general formula for the derivative and provides detailed definitions of the substituent groups involved.

Career Highlights

Lichen Meng is associated with Zhejiang Hisun Pharmaceutical Co., Ltd., where he applies his expertise in drug development. His work has contributed to advancements in therapeutic agents, enhancing treatment options for various medical conditions.

Collaborations

Lichen Meng collaborates with esteemed colleagues such as Yanghui Guo and Xiangui Huang. Their combined efforts in research and development have furthered the understanding and application of pharmaceutical compounds.

Conclusion

Lichen Meng's innovative work in the field of pharmaceutical chemistry exemplifies the impact of research on medical advancements. His contributions, particularly in the area of tetrahydroisoquinoline derivatives, highlight the importance of innovation in developing new therapeutic agents.